Frequently Asked Questions

We’ve compiled a list of answers to common questions below. 

How do I know if I am a candidate?
Our office will schedule you for an evaluation, consultation, medical records review and radiologic studies review to determine if you are a candidate. We will also determine the likelihood of success for your case.
How do Umbilical Cord Cells Actually Work?
When umbilical cord cells are placed into an environment of injured tissue, the stem cells go to work inhibiting the damaging inflammatory components and modulating the immune system. At the same time, the mononucleated cells produce growth factors that nourish damaged cells back to health and stimulate our own cells to regenerate themselves.
Does my insurance cover Stem Cell Therapy?
Unfortunately, no insurances cover stem cell therapy as they are not yet FDA approved, which makes our process and the stem cell product even more economical and desirable. We anticipate an expedited approval that will happen in 3-5 years but no one knows for sure how long it will take. It will likely come in segmental approvals for certain conditions as the human trial evidence mounts. Currently, the only FDA approved therapy is umbilical cord stem cells for a very specific cancer.
How much does it cost?
Treatments are condition specific and patient specific. The cost is determined by the number of stem cells deployed. Most patients are treated for less than the cost of braces for teeth or Lasik surgery for vision. Treatments for small joints like ankles or wrists can be treated for as little as $3,500. Larger joints require more cells so the cost increases.
Is it safe?
There are no long-term negative side effects. Temporary side effects can include redness at the procedure site, minor swelling and bruising. The small percentages of patients who experience nausea, a headache or slight fever normally have sensitivity to mild local anesthesia. Double Click to Edit
Where do the stem cells come from?
Our Stem cells come from pre planned, Caesarean section, live birth, human umbilical cord blood. Approximately 4 weeks prior to a scheduled Caesarean section, the mother’s OB/GYN asks her if she would like to keep and store her unborn child’s umbilical cord for future use. If the mother declines, she is asked if she would like to donate the umbilical cord. If she agrees, she undergoes a review of her medical history, social history, and a blood test is performed to determine if the mother is an acceptable donor.

The umbilical cord is processed in the hospital according to the rules and regulations of the American Association of Tissue Banks (AATB). est. If she is deemed an acceptable donor according to prevailing rules of the AATB, then, at the time of her caesarean section, an experienced technician will clamp the umbilical cord, take it to a sterile room, and remove the contents of the umbilical cord and place it into a blood bag. The bag of umbilical cord blood is then delivered to the lab for processing. Once at the lab, a sample of the umbilical cord blood is sent to a 3rd party independent FDA registered lab for testing according to United States Pharmacopoeia rule 71 (U.S.P. 71), which is a test for all known communicable diseases. While that test is taking place, the stem cells are then processed and removed from the red blood cell products. A sample of the finished stem cell product is then sent to a different 3rd party independent FDA registered lab for sterility testing and for the absence of HLA-DR markers. Only after both lab reports come back as “clean” and the stem cells have passed the regulatory requirements, are the processed umbilical cord stem cells available for distribution.